4 completed, 1 recruiting. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Micardis: new trials by email Literature Review of Micardis trials Research Report on Micardis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Telmisartan in Prostate Cancer Telmisartan, Standard of Care Regimen - Prostate Cancer | Phase 1 | Recruiting | Tyler J Curiel | 36 | 2024-04-22 | 2026-07-22 |
| Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State Telmisartan, Micardis - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 26 | 2018-09-07 | 2018-12-27 |
| Health Evaluation in African Americans Using RAS Therapy Telmisartan 20mg, Telmisartan 40mg, Placebo - Alzheimer's Disease | Phase 1 / Phase 2 | Completed | Emory University | 61 | 2015-04-01 | 2024-05-23 |
| CKD-828 (80/5mg) Pharmacokinetic Study CKD-828, Telmisartan, S-amlodipine - Hypertension | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 48 | 2015-02-01 | 2015-07-08 |
| CKD-828 (80/5mg) Pharmacokinetic Study CKD-828, Telmisartan, S-amlodipine - Hypertension | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 69 | 2014-09-01 | 2015-04-10 |
Hypertension (3) · Alzheimer Disease (1) · Inflammation (1) · Prostatic Neoplasms (1)
Chong Kun Dang Pharmaceutical (2) · Emory University (1) · Pharmtechnology LLC (1) · Tyler J Curiel (1)
South Korea (2) · United States (2) · Canada (1)
Young-Ran Yoon (2) · Eric Sicard, MD (1) · Rodwell Mabaera, MD (1) · Whitney Whitney, PhD (1)
1RF1AG051514 (1)